Search - tctmd.com

Displaying 241 - 260 of 15660

Sort: Relevancy | Date

Presentation TCT 2016

Interatrial Shunts in HFpEF: Focus on Corvia

Presenter: Josep Rodés-Cabau, Nir Uriel, Sanjiv Shah

November 01, 2016

Presentation TCT 2016

Pulmonary Artery Denervation for Pulmonary Hypertension II: Catheter Development, Procedure, and Acute and Late Hemodynamic Results

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Shao-Liang Chen

November 01, 2016

Presentation TCT 2016

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection With Contemporary Devices and Techniques Provides Optimal CAS Outcomes

Presenter: Sriram S. Iyer, John R. Laird Jr., William A. Gray

November 01, 2016

Presentation TCT 2016

TCT 597: Why Does Thin-Cap Fibroatheroma Cluster in the Proximal egment in Left Anterior Coronary Artery, But Are Evenly Distributed Throughout the Entire Right Coronary Artery? Results from Computational Fluid Dynamics Simulation by CT-FFR

Presenter: Eric Boersma, James E. Muller

November 01, 2016

Presentation TCT 2016

TCT 516: Instantaneous-wave Free Ratio and Fractional Flow Reserve Comparison in Patients with and Without Severe Aortic Valve Stenosis.

Presenter: Alan C. Yeung, Tim P. van de Hoef

November 01, 2016

Presentation TCT 2016

TCT 412: Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry

Presenter: Mauricio G. Cohen, Bernhard Witzenbichler

November 01, 2016

Presentation TCT 2016

Pulmonary Artery Denervation for Chronic Pulmonary Hypertension I: Experimental Insights

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Alex M. K. Rothman

November 01, 2016

Presentation TCT 2016

My Best Antegrade Case(s) of the Last Year

Presenter: Colm Hanratty, Paul Hsien-Li Kao, Jianfang Luo

November 01, 2016

Presentation TCT 2016

FFR in ACS: Specifics and Timing of Measurements

Presenter: Nick Curzen, Nils Johnson, Habib Samady

November 01, 2016

Presentation TCT 2016

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben

November 01, 2016

Presentation TCT 2016

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI

Presenter: David P. Faxon, C. Michael Gibson, Deepak L. Bhatt

November 01, 2016

Presentation TCT 2016

Venous Access Specifics: Puncture, Sheath Introduction, Traversing the IVC, and Puncture Site Closure

Presenter: Maurice Buchbinder, Saibal Kar, Sameer Gafoor

November 01, 2016

Presentation TCT 2016

Interatrial Shunts: Theoretical Basis and Unanswered Questions

Presenter: Josep Rodés-Cabau, Nir Uriel, Daniel Burkhoff

November 01, 2016

Presentation TCT 2016

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Presenter: Stephen G. Ellis, Patrick W. Serruys, Ron Waksman

November 01, 2016

Presentation TCT 2016

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Ted Feldman

November 01, 2016

Presentation TCT 2016

Atrial Septostomy for Chronic Pulmonary Hypertension

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Gagan D Singh

November 01, 2016

Presentation TCT 2016

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Presenter: Stephen G. Ellis, Patrick W. Serruys, Holger M. Nef

November 01, 2016

Presentation TCT 2016

Surgical Therapy for Chronic Pulmonary Thromboembolic Disease: Does it Work?

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Matthew D. Bacchetta

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns

November 01, 2016

Advertisement

Interatrial Shunts in HFpEF: Focus on Corvia

Pulmonary Artery Denervation for Pulmonary Hypertension II: Catheter Development, Procedure, and Acute and Late Hemodynamic Results

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection With Contemporary Devices and Techniques Provides Optimal CAS Outcomes

TCT 597: Why Does Thin-Cap Fibroatheroma Cluster in the Proximal egment in Left Anterior Coronary Artery, But Are Evenly Distributed Throughout the Entire Right Coronary Artery? Results from Computational Fluid Dynamics Simulation by CT-FFR

TCT 516: Instantaneous-wave Free Ratio and Fractional Flow Reserve Comparison in Patients with and Without Severe Aortic Valve Stenosis.

TCT 412: Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry

Pulmonary Artery Denervation for Chronic Pulmonary Hypertension I: Experimental Insights

My Best Antegrade Case(s) of the Last Year

FFR in ACS: Specifics and Timing of Measurements

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI

Venous Access Specifics: Puncture, Sheath Introduction, Traversing the IVC, and Puncture Site Closure

Interatrial Shunts: Theoretical Basis and Unanswered Questions

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Atrial Septostomy for Chronic Pulmonary Hypertension

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Surgical Therapy for Chronic Pulmonary Thromboembolic Disease: Does it Work?

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content